Recently, the gene PTPRJ (protein tyrosine phosphatase receptor type J) was identified as the candidate gene for the mouse colon cancer susceptibility locus Scc1. Its human homologue PTPRJ is frequently deleted in several cancer types, including colorectal cancer. To elucidate the role of PTPRJ loss in different stages of colorectal cancer and in its pathways of progression, we expanded the previously published comparative genomic hybridization results with novel data on loss of heterozygosity (LOH) at the PTPRJ locus. We identified a strong association between the LOH of PTPRJ and the loss of chromosomal region 18q12-21 (P ¼ 0.009). This observation is specific for progressed colorectal adenomas, suggesting that an interaction between LOH of PTPRJ and loss of 18q12-21 may be involved in the development of a more progressed form of adenomas.
18q12-21
The successive accumulation of chromosomal imbalances such as losses and gains is a common feature in the progression of colorectal tumors (Lengauer et al., 1998) . In a previous study, genome-wide analysis of such chromosomal aberrations in colorectal adenomas and carcinomas by comparative genomic hybridization (CGH) revealed seven frequent chromosomal aberrations (i.e. loss of chromosomes 8p, 15q, 17p and 18q, and gain of chromosomes 8q, 13q and 20q) that are specifically associated with adenoma to carcinoma progression (Hermsen et al., 2002) . Moreover, hierarchical cluster analysis of these results showed that these chromosomal changes were not randomly distributed, but occurred in more or less specific combinations, resulting in four clusters of colorectal adenomas and two clusters of carcinomas. These data indicated that independent chromosomal instability pathways lead to colorectal cancer progression (Hermsen et al., 2002) .
In the present report, we compared the CGH results with loss of heterozygosity (LOH) of the gene PTPRJ (protein tyrosine phosphatase receptor type J) located on human chromosome band 11p11. Recently, it was demonstrated that one copy of the PTPRJ gene is deleted in a large percentage of human sporadic colorectal, lung and breast carcinomas (Ruivenkamp et al., 2002) . In the mouse, Ptprj was positionally cloned as the only candidate gene (Ruivenkamp et al., 2002) for the mouse colon cancer susceptibility locus, Scc1 (Moen et al., 1992) . In rats, it was reported that expression of PTPRJ suppresses the malignant phenotype in transformed rat thyroid cells (Trapasso et al., 2000) . These findings implicate a role for PTPRJ in cancer. Here we further evaluate PTPRJ loss in human colorectal cancer by examining its association with other chromosomal imbalances.
Four microsatellite markers along the gene PTPRJ on chromosome 11p11 were used to compare the alleles of normal and tumor DNA of 82 informative samples, consisting of 47 colorectal adenomas and 35 colorectal carcinomas. DNA copy number losses at the region of PTPRJ were not detected by CGH, probably because there is only a small region deleted (Ruivenkamp et al., 2002) that is beyond the detection sensitivity of CGH technique. In 47% (22 of the 47) of the adenomas, we detected LOH of PTPRJ (Figure 1 ). The frequency of the LOH at PTPRJ ranged from 25% in adenomacluster 1 to 67% in adenoma-cluster 4 (Table 1 ), but this trend did not reach statistical significance, probably because of the small tumor numbers per cluster. As the clusters 3 and 4 contained predominantly progressed adenomas (containing a carcinoma part; 73%, 19 of the 26), the apparently more frequent LOH of PTPRJ in these two clusters suggests that PTPRJ deletion in their adenoma part may be related to the development of a progressed adenoma stage. LOH of PTPRJ was observed more frequently in the carcinomas (71%, 25 of the 35) than in the adenomas (P ¼ 0.052). No difference in the presence of LOH was detected between the two carcinoma-clusters (Table 1) .
We investigated possible correlations between LOH of PTPRJ and other specific cancer-associated chromosomal aberrations. In the 82 tumor samples, LOH of PTPRJ correlated strongly with the loss of chromosomal region 18q12-21 (P ¼ 0.009, Table 2 ), but not with any of the other cancer-associated chromosomal aberrations. After stratification for tumor type, we still observed a significant association between LOH of PTPRJ and loss of 18q12-21 in the 47 adenomas (P ¼ 0.004, Table 3 ).
Subsequently, we tested the association between LOH of PTPRJ and loss of 18q12-21 for the different adenoma-clusters. Since only 47 adenomas were available for screening, we could not evaluate each cluster separately. Therefore, we divided the adenomas in two groups, namely adenoma-cluster 1 plus 2 containing 21 tumors (no or only few chromosomal aberrations) and adenoma-cluster 3 plus 4 consisting of 26 tumors (numerous chromosomal aberrations). Interestingly, in adenoma-clusters 1 and 2, seven adenomas exhibited LOH of PTPRJ and only one adenoma showed loss of chromosome 18q12-21, suggesting that LOH of PTPRJ occurs earlier in colorectal tumor progression than loss of chromosome 18q12-21. In the model of Vogelstein et al. (1988) , loss of chromosome 18q is also considered as an event in later adenoma progression. Obviously, there was no significant association between the two aberrations, as only one adenoma had lost PTPRJ as well as chromosome 18q12-21. The correlation between LOH of PTPRJ and loss of 18q12-21 is highly suggestive in the adenoma-clusters 3 and 4 (P ¼ 0.064, Table 4 ). Loss of PTPRJ (58%, 15 of the 26) as well as loss of chromosome 18q12-21 (62%, 16 of the 26) also mainly occurred in these two clusters of adenomas. Furthermore, since these two adenoma-clusters contain significantly more progressed adenomas than adenomaclusters 1 and 2 (Po0.0001: 19 of the 29 versus four of 21), these data suggest that the interaction between LOH of PTPRJ and loss of 18q12-21 is specific for progressed adenomas (P ¼ 0.078 for progressed adenomas, data not shown). (Ruivenkamp et al., 2002) . Oligonucleotide primers of microsatellites were labeled with 6-FAM fluorescent dye. PCR products were run on a 3700 Automated Sequencer and analysed using Genescan Analysis s 2.1 and Genotyper s 2 software. A difference of 20% or more in the intensity ratio of the two alleles in tumor DNA compared to DNA from normal tissue has been considered as evidence for LOH A total of 82 sporadic nonfamilial colorectal tumors, consisting of 47 adenomas (24 nonprogressed adenomas, that is, simple adenomas without a focus of cancer, and 23 progressed adenomas, that is, adenomas with a focus of cancer of which the adenoma part was analysed) and 35 carcinomas (23 carcinoma parts of progressed adenomas and 12 simple carcinomas), as well as the corresponding nontumorous tissue were obtained from the archives of the Department of Pathology VU University Medical Center, Amsterdam, The Netherlands. Histopathological examination is performed by one observer (GM) on H&E sections. For each tissue sample, DNA was extracted from microdissected paraffin material (Weiss et al., 1999) . For the extraction of tumor DNA, the most tumor-rich areas were dissected allowing a maximum of 20% nontumor cell contamination (Hermsen et al., 1996; Weiss et al., 1999) In contrast to the adenomas, no statistical association between LOH of PTPRJ and loss of 18q12-21 was detected in the 35 carcinomas (including carcinoma parts of progressed adenomas). A total of 16 carcinomas exhibited loss of PTPRJ and 18q12-21, nine carcinomas showed only LOH of PTPRJ, six carcinomas lost chromosome 18q12-21 but not PTPRJ, and four carcinomas retained PTPRJ as well as 18q12-21. The absence of the statistical correlation in carcinomas is due to the high frequency of both LOH of PTPRJ (71%, 25 of the 35) and loss of 18q12-21 (62%, 22 of the 35). Obviously, if two events are very frequent, it is difficult to establish statistically that their association is most likely not random, even if it may be functionally significant.
In summary, we describe a significant association between LOH of PTPRJ and loss of chromosome 18q12-21 in progressed colorectal adenomas. A more precise determination of the smallest possible overlap of the lost segments of chromosome 18q12-21 is required to define the gene(s) possibly interacting with PTPRJ. The genes SMAD2 and SMAD4 (Moustakas et al., 2001 ) could be considered, as their loss disrupts the TGFb signaling cascade that inhibits growth and induces apoptosis. Why both chromosomal imbalances tend to accumulate in the same tumor needs to be further investigated. However, these two events may be critical steps for the development of colorectal cancer. We show here that LOH of PTPRJ is an early event in colorectal cancer, whereas loss of chromosome 18q12-21 is a later event (Vogelstein et al., 1988) . In this case, loss of chromosome 18q12-21 in colorectal adenomas that already lost PTPRJ might more effectively contribute to the development of a more progressed form of adenomas.
Abbreviation: CGH, comparative genomic hybridization; LOH, loss of heterozygosity; PTPRJ, protein tyrosine phosphatase receptor type J; Scc1, Susceptibility to colon cancer-1.
